glp-1 agonists and fertility medications their impact on GLP-1 Medications, Fertility, and Pregnancy:

These melanogenesis studies have used MT-II as a high-potency reference agonist for establishing the upper limits of pharmacologically achievable melanogenesis through MC1R activation

After 48 h, 160 l of expression medium (10 g l 1 yeast extract (Gibco, 212750), 20 g l 1 peptone (Gibco, 211677), 20 g l 1 d-galactose (Panreac, A1131), 67 mM potassium phosphate monobasic buffer pH 6.0 (Thermo Scientific, 424200250), 25 g l 1 ethanol (Scharlau, ET00062500), 2 mM copper sulfate (Merck, C7631) and 25 g ml 1 chloramphenicol (Merck, C0378)) was added to each well

Want to hear the clip yourself

The clear and soluble solution was stirred rapidly while it was allowed to cool slowly to room temperature